Want to see OFIX full AI Analyst Report?
Orthofix Medical (OFIX) Ratios
Orthofix Medical Ratios
OFIX's free cash flow for Q2 2026 was $-18.87M. For the 2026 fiscal year, OFIX's free cash flow was decreased by $-12.65M and operating cash flow was $-6.22M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.45 | 2.57 | 2.54 | 3.06 | 2.55 |
| Quick Ratio | 2.24 | 1.45 | 1.20 | 1.86 | 1.76 |
| Cash Ratio | 0.48 | 0.49 | 0.20 | 0.61 | 0.83 |
| Solvency Ratio | -0.02 | -0.17 | -0.28 | 0.10 | -0.04 |
| Operating Cash Flow Ratio | 0.20 | 0.15 | -0.28 | -0.14 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 8.37 | 0.00 | -36.60 | 0.00 | 0.00 |
| Net Current Asset Value | $ 16.24M | $ 43.12M | $ 93.86M | $ 134.22M | $ 129.83M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.20 | 0.13 | 0.05 | 0.05 |
| Debt-to-Equity Ratio | 0.51 | 0.36 | 0.20 | 0.06 | 0.07 |
| Debt-to-Capital Ratio | 0.34 | 0.26 | 0.16 | 0.06 | 0.07 |
| Long-Term Debt-to-Capital Ratio | 0.29 | 0.24 | 0.13 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.89 | 1.78 | 1.55 | 1.36 | 1.41 |
| Debt Service Coverage Ratio | 0.40 | -1.23 | -8.32 | 10.57 | -1.88 |
| Interest Coverage Ratio | -3.92 | -2.86 | -16.12 | -10.30 | -4.53 |
| Debt to Market Cap | 0.31 | 0.24 | 0.19 | 0.00 | 0.00 |
| Interest Debt Per Share | 6.19 | 5.49 | 3.42 | 1.14 | 1.33 |
| Net Debt to EBITDA | 14.82 | -2.82 | -1.06 | -1.86 | -2.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.09% | 68.28% | 65.13% | 73.18% | 75.26% |
| EBIT Margin | -8.92% | -11.79% | -18.76% | -3.56% | -2.51% |
| EBITDA Margin | 1.21% | -4.28% | -10.65% | 3.40% | 4.62% |
| Operating Profit Margin | -8.33% | -10.58% | -18.63% | -2.88% | -1.79% |
| Pretax Profit Margin | -11.04% | -15.49% | -19.91% | -3.84% | -2.91% |
| Net Profit Margin | -11.21% | -15.76% | -20.28% | -4.29% | -8.26% |
| Continuous Operations Profit Margin | -11.21% | -15.76% | -20.28% | -4.29% | -8.26% |
| Net Income Per EBT | 101.52% | 101.71% | 101.83% | 111.54% | 284.39% |
| EBT Per EBIT | 132.63% | 146.39% | 106.88% | 133.45% | 162.30% |
| Return on Assets (ROA) | -10.84% | -14.10% | -16.36% | -4.31% | -8.05% |
| Return on Equity (ROE) | -20.49% | -25.04% | -25.29% | -5.86% | -11.39% |
| Return on Capital Employed (ROCE) | -10.07% | -11.68% | -18.30% | -3.54% | -2.24% |
| Return on Invested Capital (ROIC) | -10.01% | -11.60% | -18.17% | -3.52% | -2.22% |
| Return on Tangible Assets | -15.81% | -21.02% | -24.70% | -5.81% | -10.88% |
| Earnings Yield | -15.25% | -18.92% | -30.58% | -4.79% | -6.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.06 | 5.93 | 5.83 | 5.56 | 5.91 |
| Payables Turnover | 4.63 | 5.20 | 4.46 | 4.48 | 4.34 |
| Inventory Turnover | 7.92 | 1.34 | 1.17 | 1.23 | 1.38 |
| Fixed Asset Turnover | -74.16 | 5.72 | 4.69 | 7.91 | 7.84 |
| Asset Turnover | 0.97 | 0.89 | 0.81 | 1.00 | 0.97 |
| Working Capital Turnover Ratio | 3.22 | 3.08 | 3.49 | 2.74 | 2.81 |
| Cash Conversion Cycle | 27.58 | 263.93 | 292.26 | 279.99 | 241.24 |
| Days of Sales Outstanding | 60.25 | 61.50 | 62.62 | 65.64 | 61.73 |
| Days of Inventory Outstanding | 46.09 | 272.67 | 311.45 | 295.88 | 263.55 |
| Days of Payables Outstanding | 78.76 | 70.24 | 81.81 | 81.54 | 84.04 |
| Operating Cycle | 106.34 | 334.17 | 374.07 | 361.53 | 325.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.84 | 0.68 | -1.25 | -0.57 | 0.94 |
| Free Cash Flow Per Share | -0.03 | -0.24 | -2.94 | -1.73 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | 0.96 | 0.74 | -0.74 | -0.50 | 0.94 |
| Capital Expenditure Coverage Ratio | 0.96 | 0.74 | -0.74 | -0.50 | 0.94 |
| Operating Cash Flow Coverage Ratio | 0.15 | 0.14 | -0.39 | -0.54 | 0.76 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.03 | -0.06 | -0.03 | 0.04 |
| Free Cash Flow Yield | -0.21% | -1.36% | -21.77% | -8.41% | -0.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.65 | -5.29 | -3.27 | -20.89 | -15.95 |
| Price-to-Sales (P/S) Ratio | 0.74 | 0.83 | 0.66 | 0.90 | 1.32 |
| Price-to-Book (P/B) Ratio | 1.34 | 1.32 | 0.83 | 1.22 | 1.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -472.73 | -73.28 | -4.59 | -11.89 | -548.06 |
| Price-to-Operating Cash Flow Ratio | 18.13 | 25.82 | -10.82 | -35.76 | 33.14 |
| Price-to-Earnings Growth (PEG) Ratio | 0.22 | 0.27 | -0.01 | 0.42 | 0.01 |
| Enterprise Value Multiple | 75.69 | -22.30 | -7.29 | 24.49 | 25.59 |
| Enterprise Value | 751.86M | 762.21M | 579.08M | 383.48M | 548.65M |
| EV to EBITDA | 75.69 | -22.30 | -7.29 | 24.49 | 25.59 |
| EV to Sales | 0.91 | 0.95 | 0.78 | 0.83 | 1.18 |
| EV to Free Cash Flow | -587.85 | -83.89 | -5.37 | -11.05 | -491.18 |
| EV to Operating Cash Flow | 22.55 | 29.55 | -12.66 | -33.24 | 29.70 |
| Tangible Book Value Per Share | 4.57 | 5.49 | 7.80 | 10.85 | 10.81 |
| Shareholders’ Equity Per Share | 11.28 | 13.19 | 16.30 | 16.76 | 17.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | -0.02 | -0.02 | -0.12 | -1.84 |
| Revenue Per Share | 20.62 | 20.97 | 20.33 | 22.92 | 23.59 |
| Net Income Per Share | -2.31 | -3.30 | -4.12 | -0.98 | -1.95 |
| Tax Burden | 1.02 | 1.02 | 1.02 | 1.12 | 2.84 |
| Interest Burden | 1.24 | 1.31 | 1.06 | 1.08 | 1.16 |
| Research & Development to Revenue | 0.07 | 0.09 | 0.11 | 0.11 | 0.11 |
| SG&A to Revenue | 0.56 | 0.67 | 0.19 | 0.17 | 0.15 |
| Stock-Based Compensation to Revenue | 0.03 | 0.04 | 0.05 | 0.04 | 0.03 |
| Income Quality | -0.36 | -0.20 | 0.30 | 0.58 | -0.48 |
Currency in USD
